Prosecution Insights
Last updated: April 19, 2026

Medigene Immunotherapies GmbH

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18236327 T CELL RECEPTORS AND USES THEREOF DIBRINO, MARIANNE 1641 Non-Final OA Aug 21, 2023
17625380 MAGEA10 SPECIFIC T CELL RECEPTORS AND THEIR USE ALLEN, MARIANNE P 1647 Non-Final OA Jul 27, 2023
18028025 PRAME SPECIFIC T-CELL RECEPTORS AND USES THEREOF BUTTICE, AUDREY L 1647 Non-Final OA Mar 23, 2023

Managing Medigene Immunotherapies GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month